Kalpit Patel
Stock Analyst at Wolfe Research
(4.42)
# 1,209
Out of 4,676 analysts
225
Total ratings
39.4%
Success rate
16.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kalpit Patel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Upgraded: Buy | $23 | $18.68 | +23.13% | 1 | Aug 24, 2026 | |
| SMMT Summit Therapeutics | Maintained: Hold | n/a | $13.36 | - | 1 | Aug 16, 2026 | |
| KRYS Krystal Biotech | Maintained: Hold | n/a | $356.19 | - | 2 | Aug 11, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $165 → $220 | $211.38 | +4.08% | 2 | Aug 10, 2026 | |
| ONC BeOne Medicines AG | Rated: Buy | $340 → $370 | $376.37 | -1.69% | 5 | Aug 9, 2026 | |
| CORT Corcept Therapeutics | Maintained: Sell | $50 | $123.57 | -59.54% | 4 | Jul 29, 2026 | |
| GMAB Genmab | Maintained: Buy | $32 | $34.36 | -6.87% | 2 | Jun 14, 2026 | |
| TNGX Tango Therapeutics | Upgraded: Buy | $35 | $24.77 | +41.30% | 1 | Jun 8, 2026 | |
| CGON CG Oncology | Maintained: Hold | n/a | $78.95 | - | 2 | May 26, 2026 | |
| CTMX CytomX Therapeutics | Initiated Coverage: Buy | $6 | $3.37 | +78.04% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $145 | $98.08 | +47.84% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $26.69 | - | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $10.91 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $16 | $7.08 | +125.99% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $31.35 | n/a | 2 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.57 | n/a | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 → $60 | $126.64 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $24.18 | n/a | 17 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $28 | $11.31 | n/a | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $14 | $4.39 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $7.53 | n/a | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $24 | $46.75 | n/a | 10 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $29 | $19.92 | n/a | 9 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.5 → $2 | $1.55 | n/a | 33 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $6.85 | n/a | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 → $15 | $4.16 | n/a | 5 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $2.91 | n/a | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $2.17 | n/a | 14 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $0.2215 | n/a | 5 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $11.38 | n/a | 6 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $112.11 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.17 | n/a | 6 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.47 | n/a | 10 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $6 | $0.0127 | n/a | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $76.97 | n/a | 6 | Nov 26, 2021 |
Janux Therapeutics
Aug 24, 2026
Upgraded: Buy
Price Target: $23
Current: $18.68
Upside: +23.13%
Summit Therapeutics
Aug 16, 2026
Maintained: Hold
Price Target: n/a
Current: $13.36
Upside: -
Krystal Biotech
Aug 11, 2026
Maintained: Hold
Price Target: n/a
Current: $356.19
Upside: -
Revolution Medicines
Aug 10, 2026
Maintained: Buy
Price Target: $165 → $220
Current: $211.38
Upside: +4.08%
BeOne Medicines AG
Aug 9, 2026
Rated: Buy
Price Target: $340 → $370
Current: $376.37
Upside: -1.69%
Corcept Therapeutics
Jul 29, 2026
Maintained: Sell
Price Target: $50
Current: $123.57
Upside: -59.54%
Genmab
Jun 14, 2026
Maintained: Buy
Price Target: $32
Current: $34.36
Upside: -6.87%
Tango Therapeutics
Jun 8, 2026
Upgraded: Buy
Price Target: $35
Current: $24.77
Upside: +41.30%
CG Oncology
May 26, 2026
Maintained: Hold
Price Target: n/a
Current: $78.95
Upside: -
CytomX Therapeutics
May 19, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $3.37
Upside: +78.04%
May 19, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $98.08
Upside: +47.84%
May 19, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $26.69
Upside: -
Mar 26, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $10.91
Upside: -
Oct 10, 2025
Reiterated: Buy
Price Target: $13 → $16
Current: $7.08
Upside: +125.99%
Jul 21, 2025
Maintained: Buy
Price Target: $37
Current: $31.35
Upside: n/a
Jun 16, 2025
Maintained: Buy
Price Target: $5
Current: $1.57
Upside: n/a
Jun 3, 2025
Upgraded: Buy
Price Target: $38 → $60
Current: $126.64
Upside: n/a
May 21, 2025
Reiterated: Hold
Price Target: $19
Current: $24.18
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $85 → $28
Current: $11.31
Upside: n/a
May 2, 2025
Maintained: Hold
Price Target: $17 → $14
Current: $4.39
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $9
Current: $7.53
Upside: n/a
Mar 5, 2025
Maintained: Hold
Price Target: $20 → $24
Current: $46.75
Upside: n/a
Mar 3, 2025
Maintained: Buy
Price Target: $36 → $29
Current: $19.92
Upside: n/a
Feb 26, 2025
Downgraded: Hold
Price Target: $3.5 → $2
Current: $1.55
Upside: n/a
Jan 29, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $6.85
Upside: n/a
Nov 18, 2024
Maintained: Hold
Price Target: $1 → $15
Current: $4.16
Upside: n/a
Sep 27, 2024
Reiterated: Buy
Price Target: $3
Current: $2.91
Upside: n/a
May 14, 2024
Maintained: Buy
Price Target: $10 → $7
Current: $2.17
Upside: n/a
Aug 14, 2023
Reiterated: Buy
Price Target: $12 → $14
Current: $0.2215
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $7
Current: $11.38
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $112.11
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.17
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $3.47
Upside: n/a
Jun 7, 2022
Maintained: Buy
Price Target: $12 → $6
Current: $0.0127
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $76.97
Upside: n/a